Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$47,943.00
Mar 21, 2023
222320
222320
Engage consultants to advance commercialization activities
$15,737.00
Sep 5, 2022
For-profit organization
IP Assist: Intellectual Property Strategy Engagement
995023
The Project will support development of intellectual property capacity within the Firm.
$191,920.00
Dec 1, 2021
For-profit organization
Development of Novel Encapsulation Techniques to Expand Application scope
983356
Coloursmith Labs Inc. has identified a number of high-impact applications of organic dye encapsulation that fall outside of the firm's current IP landscape. Coloursmith Labs Inc. will develop novel encapsulation designs to suit these applications and expand the scope of the technology.
$50,000.00
Jul 5, 2021
For-profit organization
PhD Research Scientist in Nanomaterials to Assist in Development of Micelle Encapsulation Technology
975142
Coloursmith will be hiring an experienced PhD-level research scientist to become a core member of the R&D team and lead research efforts in multiple development projects currently underway.
$21,676.00
Dec 20, 2020
For-profit organization
Innovation Assistance Program – Round 2.5
967901
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$50,000.00
Oct 5, 2020
For-profit organization
Preliminary Assessment of Biocompatibility for Advanced Encapsulated Optical Filtering Particle Additives for Use in Class II Medical Device Silicone Hydrogel Materials
957517
Preliminary assessment of biocompatibility for advanced encapsulated optical filtering particle additives for use in Class II medical device silicone hydrogel materials.
$293,906.00
Aug 11, 2020
215385
215385
Hire expertise and purchase specialized equipment for novel optical filtering additives
$30,000.00
Jul 15, 2020
For-profit organization
MSc Research Scientist in Polymer Chemistry to Develop and Assist in Commercialization Activities for Micelle Encapsulation Technology for Novel Materials Payload Delivery System
953720
Coloursmith Labs Inc. plans to hire a Research Chemist with experience in polymer design and organic synthesis.
$86,556.00
Jun 25, 2020
For-profit organization
Innovation Assistance Program – Round 2
960591
The funding provided from the Innovation Assistance Program is to assist innovative, early-stage small- and medium-sized enterprises that are unable to access existing COVID-19 business support.
$60,984.00
Apr 1, 2020
For-profit organization
Innovation Assistance Program
949548
The funding provided by the IAP program is intended to assist innovative small and medium-sized enterprises in the start-up phase that cannot access existing commercial support related to COVID-19.